BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,467,739 | -14.1% | 843,187 | +2.8% | 0.05% | -15.3% |
| Q2 2023 | $36,651,631 | +22.7% | 819,947 | +10.7% | 0.06% | +9.3% |
| Q1 2023 | $29,859,552 | -31.1% | 740,748 | -12.9% | 0.05% | -36.5% |
| Q4 2022 | $43,366,805 | -4.1% | 850,830 | +4.1% | 0.08% | -9.6% |
| Q3 2022 | $45,215,216 | -8.4% | 817,635 | +6.4% | 0.09% | -7.8% |
| Q2 2022 | $49,350,000 | -12.3% | 768,328 | +5.9% | 0.10% | -1.0% |
| Q1 2022 | $56,250,000 | -13.9% | 725,434 | -4.6% | 0.10% | -9.6% |
| Q4 2021 | $65,299,000 | +7.0% | 760,709 | +0.3% | 0.11% | -1.7% |
| Q3 2021 | $61,014,000 | +1.0% | 758,594 | +1.1% | 0.12% | +0.9% |
| Q2 2021 | $60,420,000 | -3.7% | 750,562 | +0.9% | 0.12% | -12.2% |
| Q1 2021 | $62,711,000 | +13.1% | 743,551 | +7.6% | 0.13% | +4.0% |
| Q4 2020 | $55,463,000 | +6.0% | 691,214 | +5.1% | 0.13% | -8.0% |
| Q3 2020 | $52,318,000 | -7.6% | 657,758 | 0.0% | 0.14% | -15.4% |
| Q2 2020 | $56,633,000 | +11.0% | 657,758 | +4.7% | 0.16% | -6.4% |
| Q1 2020 | $51,001,000 | -1.8% | 628,169 | +1.1% | 0.17% | +21.0% |
| Q4 2019 | $51,949,000 | -3.5% | 621,255 | +0.9% | 0.14% | -15.9% |
| Q3 2019 | $53,850,000 | +12.1% | 615,634 | +5.0% | 0.17% | +5.6% |
| Q2 2019 | $48,026,000 | +9.0% | 586,393 | +8.2% | 0.16% | -4.7% |
| Q1 2019 | $44,049,000 | +16.7% | 541,741 | +3.9% | 0.17% | +8.3% |
| Q4 2018 | $37,754,000 | -0.7% | 521,176 | +5.7% | 0.16% | +0.6% |
| Q3 2018 | $38,005,000 | -6.4% | 492,999 | -10.4% | 0.16% | -15.8% |
| Q2 2018 | $40,588,000 | +26.9% | 549,971 | +11.8% | 0.18% | +15.7% |
| Q1 2018 | $31,990,000 | +0.7% | 491,848 | +0.1% | 0.16% | 0.0% |
| Q4 2017 | $31,777,000 | +5.5% | 491,594 | +1.7% | 0.16% | -4.2% |
| Q3 2017 | $30,132,000 | +8.1% | 483,354 | +4.3% | 0.17% | 0.0% |
| Q2 2017 | $27,884,000 | +29.8% | 463,492 | +12.7% | 0.17% | +15.3% |
| Q1 2017 | $21,480,000 | +8.7% | 411,102 | -7.7% | 0.14% | +6.7% |
| Q4 2016 | $19,755,000 | -0.7% | 445,525 | +6.6% | 0.14% | -15.1% |
| Q3 2016 | $19,888,000 | +14.1% | 417,814 | +8.4% | 0.16% | +2.6% |
| Q2 2016 | $17,423,000 | +25.1% | 385,292 | +13.6% | 0.16% | +10.7% |
| Q1 2016 | $13,932,000 | +12.1% | 339,136 | +4.1% | 0.14% | +6.9% |
| Q4 2015 | $12,428,000 | +23.6% | 325,754 | +6.4% | 0.13% | +3.1% |
| Q3 2015 | $10,053,000 | -25.6% | 306,028 | +55.0% | 0.13% | -34.9% |
| Q1 2015 | $13,521,000 | +9.1% | 197,394 | +16.7% | 0.20% | -6.7% |
| Q4 2014 | $12,398,000 | -6.3% | 169,165 | -8.3% | 0.21% | -0.5% |
| Q3 2014 | $13,238,000 | – | 184,455 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |